Skip to Main Content

Paper Details

Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study.
J Hematol Oncol
18
2022
Author NameAffiliation
Bijal ShahMoffitt Cancer Center
John T SchillerDavid Geffen School of Medicine at university of california los angeles
Daniel J DeAngeloDana-Farber Cancer Institute
  • 1 - 3

Datasets

Release 1.2